1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F97B2E579A73D7F185256C92004E8A42
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-early-stage-new-oncology-product-planning-benchmarks?opendocument
18
19opendocument
2018.97.14.85
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Marketing Management » Marketing in Oncology

Early-Stage New Oncology Product Planning Activity Benchmarks

DB Image

ID: 4380


Features:

Metrics, Graphics


Pages/Slides: 14


Published: Pre-2020


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
The Research and Advisory Services prepared this research on market planning for oncology products. This powerpoint presentation offers lessons learned in from six major pharmaceutical companies.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
AstraZeneca; Sanofi-aventis; Bayer; Bristol-Myers Squibb; Novartis; Schering-Plough

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.